Tetraploidy and tumor development
Tetraploidy and tumor development |
https://doi.org/10.18632/oncotarget.2790
Sanghee Lim,
and Neil J. Ganem
|
10959-10960 |
Angiostatic vaccines, an underestimated approach of cancer therapy
Angiostatic vaccines, an underestimated approach of cancer therapy |
https://doi.org/10.18632/oncotarget.2791
Arjan W. Griffioen
|
10961-10962 |
ADAM10 and ADAM17: New Players in Trastuzumab Resistance
ADAM10 and ADAM17: New Players in Trastuzumab Resistance |
https://doi.org/10.18632/oncotarget.2794
Michael J. Duffy,
John Crown,
and Maeve Mullooly
|
10963-10964 |
Double-punching PMBL |
https://doi.org/10.18632/oncotarget.2827
Jochen K. Lennerz
|
10965-10966 |
Reciprocity in breast cancer progression
Reciprocity in breast cancer progression |
https://doi.org/10.18632/oncotarget.2853
Christian Gespach
|
10967-10968 |
Critical role of NF-κB in pancreatic cancer
Critical role of NF-κB in pancreatic cancer |
https://doi.org/10.18632/oncotarget.2624
Lakshmi Prabhu,
Rasika Mundade,
Murray Korc,
Patrick J. Loehrer,
and Tao Lu
|
10969-10975 |
A pathophysiological view of the long non-coding RNA world
A pathophysiological view of the long non-coding RNA world |
https://doi.org/10.18632/oncotarget.2770
Federico Di Gesualdo,
Sergio Capaccioli,
and Matteo Lulli
|
10976-10996 |
Oncotargeting G proteins: The Hippo in the room
Oncotargeting G proteins: The Hippo in the room |
https://doi.org/10.18632/oncotarget.2815
Xiaodong Feng,
Qianming Chen,
and J. Silvio Gutkind
|
10997-10999 |
Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat
Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat |
https://doi.org/10.18632/oncotarget.2769
Kangxing Song,
Shuxia Wang,
Mitra Mani,
and Arya Mani
|
11000-11003 |
Bioinformatics analysis of the serine and glycine pathway in cancer cells
Bioinformatics analysis of the serine and glycine pathway in cancer cells |
https://doi.org/10.18632/oncotarget.2668
Alexey Antonov,
Massimiliano Agostini,
Maria Morello,
Marilena Minieri,
Gerry Melino,
and Ivano Amelio
|
11004-11013 |
Revealed: The spy who regulates neuroblastoma stem cells
Revealed: The spy who regulates neuroblastoma stem cells |
https://doi.org/10.18632/oncotarget.2839
Parvez Vora,
Chitra Venugopal,
and Sheila K. Singh
|
11014-11016 |
Surgical procedures and postsurgical tissue processing significantly affect expression of genes and EGFR-pathway proteins in colorectal cancer tissue
Surgical procedures and postsurgical tissue processing significantly affect expression of genes and EGFR-pathway proteins in colorectal cancer tissue |
https://doi.org/10.18632/oncotarget.2669
Kerstin A. David,
Florian T. Unger,
Philipp Uhlig,
Hartmut Juhl,
Helen M. Moore,
Carolyn Compton,
Björn Nashan,
Arnulf Dörner,
Andreas de Weerth,
and Carsten Zornig
|
11017-11028 |
Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition
Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition |
https://doi.org/10.18632/oncotarget.2789
Rebecca Lamb,
Hannah Harrison,
James Hulit,
Duncan L. Smith,
Michael P. Lisanti,
and Federica Sotgia
|
11029-11037 |
Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer
Curaxin CBL0137 eradicates drug resistant cancer stem cells and potentiates efficacy of gemcitabine in preclinical models of pancreatic cancer |
https://doi.org/10.18632/oncotarget.2701
Catherine Burkhart,
Daria Fleyshman,
Rachael Kohrn,
Mairead Commane,
Jennifer Garrigan,
Vadim Kurbatov,
Ilya Toshkov,
Rajesh Ramachandran,
Laura Martello,
and Katerina V. Gurova
|
11038-11053 |
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer |
https://doi.org/10.18632/oncotarget.2609
Emilio Bria,
Francesca Di Modugno,
Isabella Sperduti,
Pierluigi Iapicca,
Paolo Visca,
Gabriele Alessandrini,
Barbara Antoniani,
Sara Pilotto,
Vienna Ludovini,
Jacopo Vannucci,
Guido Bellezza,
Angelo Sidoni,
Giampaolo Tortora,
Derek C. Radisky,
Lucio Crinò,
Francesco Cognetti,
Francesco Facciolo,
Marcella Mottolese,
Michele Milella,
and Paola Nisticò
|
11054-11063 |
IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival |
https://doi.org/10.18632/oncotarget.2519
Serena Lunardi,
Nigel B. Jamieson,
Su Yin Lim,
Kristin L. Griffiths,
Manuela Carvalho-Gaspar,
Osama Al-Assar,
Sabira Yameen,
Ross C. Carter,
Colin J. McKay,
Gabriele Spoletini,
Stefano D’Ugo,
Michael A. Silva,
Owen J. Sansom,
Klaus-Peter Janssen,
Ruth J. Muschel,
and Thomas B. Brunner
|
11064-11080 |
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer |
https://doi.org/10.18632/oncotarget.2404
Alejandro Berlin,
Emilie Lalonde,
Jenna Sykes,
Gaetano Zafarana,
Kenneth C. Chu,
Varune R. Ramnarine,
Adrian Ishkanian,
Dorota H.S. Sendorek,
Ivan Pasic,
Wan L. Lam,
Igor Jurisica,
Theo van der Kwast,
Michael Milosevic,
Paul C. Boutros,
and Robert G. Bristow
|
11081-11090 |
Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer
Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer |
https://doi.org/10.18632/oncotarget.2691
Fubo Wang,
Shancheng Ren,
Rui Chen,
Ji Lu,
Xiaolei Shi,
Yasheng Zhu,
Wei Zhang,
Taile Jing,
Chao Zhang,
Jian Shen,
Chuanliang Xu,
Huiqing Wang,
Haifeng Wang,
Yang Wang,
Bin Liu,
Yaoming Li,
Ziyu Fang,
Fei Guo,
Meng Qiao,
Chengyao Wu,
Qiang Wei,
Danfeng Xu,
Dan Shen,
Xin Lu,
Xu Gao,
Jianguo Hou,
and Yinghao Sun
|
11091-11102 |
Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma
Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.2549
Xiang Qi,
Kevin Tak Pan Ng,
Qi Zhou Lian,
Xiao Bing Liu,
Chang Xian Li,
Wei Geng,
Chang Chun Ling,
Yuen Yuen Ma,
Wai Ho Yeung,
Wen Wei Tu,
Sheung Tat Fan,
Chung Mau Lo,
and Kwan Man
|
11103-11120 |
Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy
Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomy |
https://doi.org/10.18632/oncotarget.2553
Peng-Yuan Zhuang,
Jian-Dong Wang,
Zhao-Hui Tang,
Xue-Ping Zhou,
Yong Yang,
Zhi-Wei Quan,
Ying-Bin Liu,
and Jun Shen
|
11121-11132 |
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal |
https://doi.org/10.18632/oncotarget.2563
Cathy Eng,
George J. Chang,
Y. Nancy You,
Prajnan Das,
Miguel Rodriguez-Bigas,
Yan Xing,
Jean-Nicolas Vauthey,
Jane E. Rogers,
Aki Ohinata,
Priyanka Pathak,
Salil Sethi,
Jonathan K. Phillips,
Christopher H. Crane,
and Robert A. Wolff
|
11133-11142 |
Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial
Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial |
https://doi.org/10.18632/oncotarget.2603
Giovanni Bisceglia,
Nicola Mastrodonato,
Berardino Tardio,
Gianluigi Mazzoccoli,
Pietro Corsa,
Michele Troiano,
and Salvatore Parisi
|
11143-11153 |
A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours
A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours |
https://doi.org/10.18632/oncotarget.2568
David S. Hong,
Razelle Kurzrock,
Marilyn Mulay,
Erik Rasmussen,
Benjamin M. Wu,
Michael B. Bass,
Zhandong D. Zhong,
Greg Friberg,
and Lee S. Rosen
|
11154-11167 |
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience
Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience |
https://doi.org/10.18632/oncotarget.2584
Ming-Mo Hou,
Xiaochun Liu,
Jennifer Wheler,
Aung Naing,
David Hong,
Robert L. Coleman,
Apostolia Tsimberidou,
Filip Janku,
Ralph Zinner,
Karen Lu,
Razelle Kurzrock,
and Siqing Fu
|
11168-11179 |
Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells
Neuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells |
https://doi.org/10.18632/oncotarget.2611
Kristian W. Pajtler,
Ellen Mahlow,
Andrea Odersky,
Sven Lindner,
Harald Stephan,
Ivo Bendix,
Angelika Eggert,
Alexander Schramm,
and Johannes H. Schulte
|
11180-11192 |
The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic
The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic |
https://doi.org/10.18632/oncotarget.1933
Liesbeth Bieghs,
Susanne Lub,
Karel Fostier,
Ken Maes,
Els Van Valckenborgh,
Eline Menu,
Hans E. Johnsen,
Michael T. Overgaard,
Olle Larsson,
Magnus Axelson,
Mette Nyegaard,
Rik Schots,
Helena Jernberg-Wiklund,
Karin Vanderkerken,
and Elke De Bruyne
|
11193-11208 |
Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer
Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer |
https://doi.org/10.18632/oncotarget.2026
Yongzhang Liu,
Linhua Lan,
Kate Huang,
Rongrong Wang,
Cuicui Xu,
Yang Shi,
Xiaoyi Wu,
Zhi Wu,
Jiliang Zhang,
Lin Chen,
Lu Wang,
Xiaomin Yu,
Haibo Zhu,
and Bin Lu
|
11209-11224 |
Maspin expression in prostate tumor elicits host anti-tumor immunity
Maspin expression in prostate tumor elicits host anti-tumor immunity |
https://doi.org/10.18632/oncotarget.2615
Sijana H. Dzinic,
Kang Chen,
Archana Thakur,
Alexander Kaplun,
R. Daniel Bonfil,
Xiaohua Li,
Jason Liu,
M. Margarida Bernardo,
Allen Saliganan,
Jessica B. Back,
Hiroshi Yano,
Dana L. Schalk,
Elyse N. Tomaszewski,
Ahmed S. Beydoun,
Gregory Dyson,
Adelina Mujagic,
David Krass,
Ivory Dean,
Qing-Sheng Mi,
Elisabeth Heath,
Wael Sakr,
Lawrence G. Lum,
and Shijie Sheng
|
11225-11236 |
Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells
Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells |
https://doi.org/10.18632/oncotarget.2616
Yi Lun Liu,
Fritz Lai,
James S. Wilmott,
Xu Guang Yan,
Xiao Ying Liu,
Qi Luan,
Su Tang Guo,
Chen Chen Jiang,
Hsin-Yi Tseng,
Richard A. Scolyer,
Lei Jin,
and Xu Dong Zhang
|
11237-11251 |
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current
Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current |
https://doi.org/10.18632/oncotarget.2617
Marta Gritti,
Roberto Würth,
Marina Angelini,
Federica Barbieri,
Marta Peretti,
Erika Pizzi,
Alessandra Pattarozzi,
Elisa Carra,
Rodolfo Sirito,
Antonio Daga,
Paul M.G. Curmi,
Michele Mazzanti,
and Tullio Florio
|
11252-11268 |
Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression
Apoptin enhances the oncolytic properties of vaccinia virus and modifies mechanisms of tumor regression |
https://doi.org/10.18632/oncotarget.2579
Galina Kochneva,
Evgeniy Zonov,
Antonina Grazhdantseva,
Anastasiya Yunusova,
Galina Sibolobova,
Evgeniy Popov,
Oleg Taranov,
Sergei Netesov,
Peter Chumakov,
and Elena Ryabchikova
|
11269-11282 |
Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype
Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype |
https://doi.org/10.18632/oncotarget.2207
Katia Beider,
Hanna Bitner,
Merav Leiba,
Odit Gutwein,
Maya Koren-Michowitz,
Olga Ostrovsky,
Michal Abraham,
Hanna Wald,
Eithan Galun,
Amnon Peled,
and Arnon Nagler
|
11283-11296 |
DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells
DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells |
https://doi.org/10.18632/oncotarget.2315
Shinichiro Fukuhara,
Inik Chang,
Yozo Mitsui,
Takeshi Chiyomaru,
Soichiro Yamamura,
Shahana Majid,
Sharanjot Saini,
Hiroshi Hirata,
Guoren Deng,
Ankurpreet Gill,
Darryn K. Wong,
Hiroaki Shiina,
Norio Nonomura,
Rajvir Dahiya,
and Yuichiro Tanaka
|
11297-11307 |
Therapeutic potential of ERK5 targeting in triple negative breast cancer
Therapeutic potential of ERK5 targeting in triple negative breast cancer |
https://doi.org/10.18632/oncotarget.2324
María Jesús Ortiz-Ruiz,
Stela Álvarez-Fernández,
Tracy Parrott,
Sara Zaknoen,
Francis J. Burrows,
Alberto Ocaña,
Atanasio Pandiella,
and Azucena Esparís-Ogando
|
11308-11318 |
EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma
EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma |
https://doi.org/10.18632/oncotarget.2435
Juan Lu,
Fei-Peng Zhao,
Zengliu Peng,
Meng-Wen Zhang,
Shao-Xiong Lin,
Bi-Jun Liang,
Bao Zhang,
Xiong Liu,
Lu Wang,
Gang Li,
Wen-Dong Tian,
Ying Peng,
Ming-Liang He,
and Xiang-Ping Li
|
11319-11332 |
Overexpression of human β-defensin 2 promotes growth and invasion during esophageal carcinogenesis
Overexpression of human β-defensin 2 promotes growth and invasion during esophageal carcinogenesis |
https://doi.org/10.18632/oncotarget.2416
Ni Shi,
Feng Jin,
Xiaoli Zhang,
Steven K. Clinton,
Zui Pan,
and Tong Chen
|
11333-11344 |
Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancer
Interactome analysis of myeloid-derived suppressor cells in murine models of colon and breast cancer |
https://doi.org/10.18632/oncotarget.2489
Alexander M. Aliper,
Victoria P. Frieden-Korovkina,
Anton Buzdin,
Sergey A. Roumiantsev,
and Alex Zhavoronkov
|
11345-11353 |
Identification and validation of p50 as the cellular target of eriocalyxin B
Identification and validation of p50 as the cellular target of eriocalyxin B |
https://doi.org/10.18632/oncotarget.2461
Ling-Mei Kong,
Xu Deng,
Zhi-Li Zuo,
Han-Dong Sun,
Qin-Shi Zhao,
and Yan Li
|
11354-11364 |
Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells
Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells |
https://doi.org/10.18632/oncotarget.2497
Xuan Zhang,
Lihua Cheng,
Kay Minn,
Rashna Madan,
Andrew K. Godwin,
Viji Shridhar,
and Jeremy Chien
|
11365-11380 |
Human PIF1 helicase supports DNA replication and cell growth under oncogenic-stress
Human PIF1 helicase supports DNA replication and cell growth under oncogenic-stress |
https://doi.org/10.18632/oncotarget.2501
Mary E. Gagou,
Anil Ganesh,
Geraldine Phear,
Darren Robinson,
Eva Petermann,
Angela Cox,
and Mark Meuth
|
11381-11398 |
Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition
Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition |
https://doi.org/10.18632/oncotarget.2550
Hiroki Tamaki,
Nanae Harashima,
Miho Hiraki,
Naoko Arichi,
Nobuhiro Nishimura,
Hiroaki Shiina,
Kohji Naora,
and Mamoru Harada
|
11399-11412 |
Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1
Chemopreventive apigenin controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1 |
https://doi.org/10.18632/oncotarget.2551
Xin Tong,
Salida Mirzoeva,
Dorina Veliceasa,
Bryan B. Bridgeman,
Philip Fitchev,
Mona L. Cornwell,
Susan E. Crawford,
Jill C. Pelling,
and Olga V. Volpert
|
11413-11427 |
Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance
Downregulated MTAP expression in myxofibrosarcoma: A characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevance |
https://doi.org/10.18632/oncotarget.2552
Chien-Feng Li,
Fu-Min Fang,
Hsing-Jien Kung,
Li-Tzong Chen,
Jun-Wen Wang,
Jen-Wei Tsai,
Shih Chen Yu,
Yu-Hui Wang,
Shau-Hsuan Li,
and Hsuan-Ying Huang
|
11428-11441 |
Senescence of tumor cells induced by oxaliplatin increases the efficiency of a lipid A immunotherapy via the recruitment of neutrophils
Senescence of tumor cells induced by oxaliplatin increases the efficiency of a lipid A immunotherapy via the recruitment of neutrophils |
https://doi.org/10.18632/oncotarget.2556
Cédric Seignez,
Amandine Martin,
Claire-Emmanuelle Rollet,
Cindy Racoeur,
Alessandra Scagliarini,
Jean-François Jeannin,
Ali Bettaieb,
and Catherine Paul
|
11442-11451 |
Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells
Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells |
https://doi.org/10.18632/oncotarget.2576
Annat Raiter,
Rinat Yerushalmi,
and Britta Hardy
|
11452-11463 |
Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent
Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent |
https://doi.org/10.18632/oncotarget.2562
Liron Nesiel-Nuttman,
Betty Schwartz,
and Oded Shoseyov
|
11464-11478 |
Mastl kinase, a promising therapeutic target, promotes cancer recurrence
Mastl kinase, a promising therapeutic target, promotes cancer recurrence |
https://doi.org/10.18632/oncotarget.2565
Ling Wang,
Vivian Q. Luong,
Peter J. Giannini,
and Aimin Peng
|
11479-11489 |
CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1
CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1 |
https://doi.org/10.18632/oncotarget.2571
Arun Bhardwaj,
Sanjeev K. Srivastava,
Seema Singh,
Sumit Arora,
Nikhil Tyagi,
Joel Andrews,
Steven McClellan,
James E. Carter,
and Ajay P. Singh
|
11490-11500 |
Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support
Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support |
https://doi.org/10.18632/oncotarget.2572
Jeannette Boutter,
Yun Huang,
Blerim Marovca,
Andreas Vonderheit,
Michael A. Grotzer,
Cornelia Eckert,
Gunnar Cario,
Bernd Wollscheid,
Peter Horvath,
Beat C. Bornhauser,
and Jean-Pierre Bourquin
|
11501-11512 |
STAT3 inhibition suppresses proliferation of retinoblastoma through down-regulation of positive feedback loop of STAT3/miR-17-92 clusters
STAT3 inhibition suppresses proliferation of retinoblastoma through down-regulation of positive feedback loop of STAT3/miR-17-92 clusters |
https://doi.org/10.18632/oncotarget.2546
Dong Hyun Jo,
Jin Hyoung Kim,
Chang Sik Cho,
Young-Lai Cho,
Hyoung Oh Jun,
Young Suk Yu,
Jeong-Ki Min,
and Jeong Hun Kim
|
11513-11525 |
A novel DAG-dependent mechanism links PKCɑ and Cyclin B1 regulating cell cycle progression
A novel DAG-dependent mechanism links PKCɑ and Cyclin B1 regulating cell cycle progression |
https://doi.org/10.18632/oncotarget.2578
Alessandro Poli,
Giulia Ramazzotti,
Alessandro Matteucci,
Lucia Manzoli,
Annalisa Lonetti,
Pann-Ghill Suh,
James A. McCubrey,
and Lucio Cocco
|
11526-11540 |
Inhibition of glioblastoma malignancy by Lgl1
Inhibition of glioblastoma malignancy by Lgl1 |
https://doi.org/10.18632/oncotarget.2580
Alexander Gont,
Jennifer E. L. Hanson,
Sylvie J. Lavictoire,
Manijeh Daneshmand,
Garth Nicholas,
John Woulfe,
Amin Kassam,
Vasco F. Da Silva,
and Ian A. J. Lorimer
|
11541-11551 |
Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters
Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters |
https://doi.org/10.18632/oncotarget.2594
Qiong Wu,
Zhiping Yang,
Lin Xia,
Yongzhan Nie,
Kaichun Wu,
Yongquan Shi,
and Daiming Fan
|
11552-11563 |
High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients
High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients |
https://doi.org/10.18632/oncotarget.2595
Yu-Jen Cheng,
Yi-Chen Lee,
Wen-Chin Chiu,
Jen-Wei Tsai,
Yu-Han Su,
Amos C. Hung,
Po-Chih Chang,
Chih-Jen Huang,
Chee-Yin Chai,
and Shyng-Shiou F. Yuan
|
11564-11575 |
Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway
Suppression of esophageal tumor growth and chemoresistance by directly targeting the PI3K/AKT pathway |
https://doi.org/10.18632/oncotarget.2596
Bin Li,
Jin Li,
Wen Wen Xu,
Xin Yuan Guan,
Yan Ru Qin,
Li Yi Zhang,
Simon Law,
Sai Wah Tsao,
and Annie L.M. Cheung
|
11576-11587 |
AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis
AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis |
https://doi.org/10.18632/oncotarget.2597
Chien-Feng Li,
Li-Tzong Chen,
Jui Lan,
Fong-Fu Chou,
Ching-Yih Lin,
Yen-Yang Chen,
Tzu-Ju Chen,
Shau-Hsuan Li,
Shih-Chen Yu,
Fu-Ming Fang,
Hui-Chun Tai,
and Hsuan-Ying Huang
|
11588-11603 |
RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo |
https://doi.org/10.18632/oncotarget.2598
Wei Wang,
Jianwen Cheng,
Jiang-Jiang Qin,
Sukesh Voruganti,
Subhasree Nag,
Jia Fan,
Qiang Gao,
and Ruiwen Zhang
|
11604-11619 |
Activation of miR-9 by human papillomavirus in cervical cancer
Activation of miR-9 by human papillomavirus in cervical cancer |
https://doi.org/10.18632/oncotarget.2599
Weijun Liu,
Ge Gao,
Xiaoxia Hu,
Yuhui Wang,
Julie K. Schwarz,
Jason J. Chen,
Perry W. Grigsby,
and Xiaowei Wang
|
11620-11630 |
Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK
Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK |
https://doi.org/10.18632/oncotarget.2600
Xiaoying Zhou,
Guifang Xu,
Chengqiang Yin,
Wujuan Jin,
and Guoxin Zhang
|
11631-11640 |
Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma
Cisplatin in combination with Phenethyl Isothiocyanate (PEITC), a potential new therapeutic strategy for malignant pleural mesothelioma |
https://doi.org/10.18632/oncotarget.2604
Iza Denis,
Laurent Cellerin,
Marc Gregoire,
and Christophe Blanquart
|
11641-11652 |
Dysregulation of autophagy in human follicular lymphoma is independent of overexpression of BCL-2
Dysregulation of autophagy in human follicular lymphoma is independent of overexpression of BCL-2 |
https://doi.org/10.18632/oncotarget.2605
Aine McCarthy,
Jacek Marzec,
Andrew Clear,
Robert D. Petty,
Rita Coutinho,
Janet Matthews,
Andrew Wilson,
Sameena Iqbal,
Maria Calaminici,
John G. Gribben,
and Li Jia
|
11653-11668 |
MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma
MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.2581
Ye Song,
Jiangchao Li,
Yinghui Zhu,
Yongdong Dai,
Tingting Zeng,
Lulu Liu,
Jianbiao Li,
Hongbo Wang,
Yanru Qin,
Musheng Zeng,
Xin-Yuan Guan,
and Yan Li
|
11669-11680 |
Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo-sensitivity and prognosis
Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo-sensitivity and prognosis |
https://doi.org/10.18632/oncotarget.2585
Xing Liu,
Xiaofeng Wang,
Wenzhong Du,
Lingchao Chen,
Guangzhi Wang,
Yuqiong Cui,
Yang Liu,
Zhijin Dou,
Hongjun Wang,
Ping Zhang,
Liang Chang,
Liye Yi,
Jinquan Cai,
and Chuanlu Jiang
|
11681-11694 |
Gastrokine 1 induces senescence and apoptosis through regulating telomere length in gastric cancer
Gastrokine 1 induces senescence and apoptosis through regulating telomere length in gastric cancer |
https://doi.org/10.18632/oncotarget.2586
Jung Hwan Yoon,
Ho Seok Seo,
Won Seok Choi,
Olga Kim,
Suk Woo Nam,
Jung Young Lee,
and Won Sang Park
|
11695-11708 |
Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma
Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma |
https://doi.org/10.18632/oncotarget.2606
Ambrish Kumar,
Nadia Al-Sammarraie,
Donald J. DiPette,
and Ugra S. Singh
|
11709-11722 |
MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors
MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors |
https://doi.org/10.18632/oncotarget.2607
Yuan-Shuo Hsueh,
Hui Hua Chang,
Nai-Jung Chiang,
Chueh-Chuan Yen,
Chien-Feng Li,
and Li-Tzong Chen
|
11723-11736 |
Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5-FU and L-OHP
Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5-FU and L-OHP |
https://doi.org/10.18632/oncotarget.2591
Davide Esposito,
Elvira Crescenzi,
Vinay Sagar,
Fabrizio Loreni,
Annapina Russo,
and Giulia Russo
|
11737-11751 |